(Reuters) – The U.S. Food and Drug Administration (FDA) said on Friday it had granted emergency use authorization to Eli Lilly and Co’s COVID-19 antibody drug for the treatment of patients with mild to moderate disease who are 12 years and older.
(Reporting by Amruta Khandekar; Editing by Aditya Soni)
